Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...
NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 05, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...
NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 23, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...
TORONTO and HERZILA, Israel, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Organigram Holdings Inc. (NASDAQ: OGI) (TSX:...
Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure with up to 20,000 kg of dried flower over multiple years Organigram...
NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) -- In a release issued under the...
Eleventh consecutive quarter of sequential profitable revenue growth Annualized revenue run rate of $155...
Estimated revenue reaches CAD$39 million1 (a record of over NIS 100 million): Eleventh consecutive quarter of...
HERZLIYA, Israel, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Intercure Ltd. (the “Company”) announces today the...
Record revenue of over $37 millioni in the second quarter of 2022 Representing an annual run rate of $150...
NEW YORK and TORONTO and HERZLIYA, Israel, Aug. 11, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...
Estimated revenue reaches CAD$36 million 1(a record NIS 95 million) Anticipates continued increases in EBITDA...
NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...
NEW YORK and TORONTO and HERZLIYA, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...
Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지